Terns Pharmaceuticals Stock Probability of Future Stock Price Finishing Under 6.25
| TERN Stock | USD 5.80 0.13 2.19% |
Terns |
Terns Pharmaceuticals Target Price Odds to finish below 6.25
The tendency of Terns Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under $ 6.25 after 90 days |
| 5.80 | 90 days | 6.25 | about 19.9 |
Based on a normal probability distribution, the odds of Terns Pharmaceuticals to stay under $ 6.25 after 90 days from now is about 19.9 (This Terns Pharmaceuticals probability density function shows the probability of Terns Stock to fall within a particular range of prices over 90 days) . Probability of Terns Pharmaceuticals price to stay between its current price of $ 5.80 and $ 6.25 at the end of the 90-day period is about 10.57 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.92 . This usually implies as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Terns Pharmaceuticals will likely underperform. Additionally Terns Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Terns Pharmaceuticals Price Density |
| Price |
Predictive Modules for Terns Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Terns Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Terns Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Terns Pharmaceuticals is not an exception. The market had few large corrections towards the Terns Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Terns Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Terns Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.77 | |
β | Beta against Dow Jones | 1.92 | |
σ | Overall volatility | 0.95 | |
Ir | Information ratio | -0.18 |
Terns Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Terns Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Terns Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Terns Pharmaceuticals generated a negative expected return over the last 90 days | |
| Terns Pharmaceuticals has high historical volatility and very poor performance | |
| Terns Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (90.21 M) with profit before overhead, payroll, taxes, and interest of 1000 K. | |
| Terns Pharmaceuticals currently holds about 139.81 M in cash with (67.39 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.51. | |
| Terns Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Over 98.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Tern Shares Down 8.1 percent Whats Next |
Terns Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Terns Stock often depends not only on the future outlook of the current and potential Terns Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Terns Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 71.3 M | |
| Cash And Short Term Investments | 263.4 M |
Terns Pharmaceuticals Technical Analysis
Terns Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Terns Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Terns Pharmaceuticals. In general, you should focus on analyzing Terns Stock price patterns and their correlations with different microeconomic environments and drivers.
Terns Pharmaceuticals Predictive Forecast Models
Terns Pharmaceuticals' time-series forecasting models is one of many Terns Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Terns Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Terns Pharmaceuticals
Checking the ongoing alerts about Terns Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Terns Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Terns Pharmaceuticals generated a negative expected return over the last 90 days | |
| Terns Pharmaceuticals has high historical volatility and very poor performance | |
| Terns Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (90.21 M) with profit before overhead, payroll, taxes, and interest of 1000 K. | |
| Terns Pharmaceuticals currently holds about 139.81 M in cash with (67.39 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.51. | |
| Terns Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Over 98.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Tern Shares Down 8.1 percent Whats Next |
Check out Terns Pharmaceuticals Backtesting, Terns Pharmaceuticals Valuation, Terns Pharmaceuticals Correlation, Terns Pharmaceuticals Hype Analysis, Terns Pharmaceuticals Volatility, Terns Pharmaceuticals History as well as Terns Pharmaceuticals Performance. To learn how to invest in Terns Stock, please use our How to Invest in Terns Pharmaceuticals guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Terns Pharmaceuticals. If investors know Terns will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Terns Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.18) | Revenue Per Share 0.035 | Return On Assets (0.19) | Return On Equity (0.28) |
The market value of Terns Pharmaceuticals is measured differently than its book value, which is the value of Terns that is recorded on the company's balance sheet. Investors also form their own opinion of Terns Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Terns Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Terns Pharmaceuticals' market value can be influenced by many factors that don't directly affect Terns Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Terns Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Terns Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Terns Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.